2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hematologic Neoplasms
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Small Intestinal Neuroendocrine Tumor
1
Papillomavirus Infections
1
Pancreatic Adenocarcinoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Heart Failure
1
HER2-positive Breast Cancer
1
Cystic Fibrosis
1
Cardiomyopathies
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Gemcitabine
13
Albumin-Bound Paclitaxel
8
Taxes
6
130-nm albumin-bound paclitaxel
6
Fluorouracil
5
Oxaliplatin
4
dehydroftorafur
3
Radiotherapy, Intensity-Modulated
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
Losartan
2
Cisplatin
2
tocilizumab
1
selicrelumab
1
niraparib
1
irinotecan sucrosofate
1
indusatumab
1
folfirinox
1
durvalumab
1
cobimetinib
1
atezolizumab
1
X-Rays
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
S 1 (combination)
1
Resistance Training
1
Radiotherapy, Image-Guided
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Adenocarcinoma
×
Electronic Health Records
×
Clear all
NCT04406571
2024-01-24
CAPANCOVID-19
CHU de Reims
Completed
700 enrolled